YOKNEAM, Israel, Nov. 15, 2016 -- Pollogen Ltd., a Lumenis-owned company specializing in the development of innovative medical devices for the aesthetics market, announced today the release of the Divine Pro™ at Cosmoprof Asia, November 16-18 at their booth 3E K2B.
|
|||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eb5d872d-91ec-42e4-8cd0-414163de6b03
The Divine Pro™ is a multi-solution platform providing facial rejuvenation, including dermal volumizing and skin firming, while having a comfortable treatment experience. The Divine Pro incorporates a winning combination of clinically proven technologies: VoluDerm micro-needling with Radio-Frequency (RF), TriPollar RF with Dynamic Muscle Activation (DMA) and TriFractional RF. These multi-dimensional treatments work together to renew the deep dermis, mid-dermis and epidermis to provide a holistic approach for repairing signs of aging.
Dr. Steven D. Shapiro of Palm Beach Gardens, FL commented on his experiences with VoluDerm treatments: “I find that VoluDerm micro-needling with its 4th generation radio frequency is a great treatment for the face. It is fantastic for tissue tightening, volumizing, removal of dark spots on the surface of the skin and shrinkage of pore size. On some patients we find that the benefits approach surgical treatment results.”
Dr. Sheila Barbarino, a leading aesthetic expert from Hermosa Beach, CA, will discuss her experience with the Divine Pro advanced solutions at the Lumenis booth and share how they can help clinics and spas to grow their business.
The following lectures will be held in the booth:
November 17 - 2:00 PM
VoluDerm & TriPollar - Combining Micro-needling & RF for Rapid Volumizing & Skin Tightening, Dr. Sheila Barbarino
November 18 - 2:00 PM
LightSheer Beauty - Reinvent the business of hair removal, Dr. Sheila Barbarino
Also on display at the booth:
- The flagship Lumenis M22™ system for treatment of over 30 skin conditions and hair removal
- The LightSheer® Beauty™ for permanent hair reduction
- The Pollogen LEGEND for dermal volumizing and body contouring
- The Pollogen geneO+ for a 3-in-1 Super Facial
About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information visit: www.lumenis.com.
About Pollogen, a Lumenis owned company
Pollogen Ltd., provides innovative, safe, and effective solutions for women and men that enhance and expand the practice of medical aesthetics professionals. The company offers products to address a range of skin treatments under the industry’s six premier brands: TriPollar®, TriLipo®, TriFractional™, OxyGeneo®, Hybrid Energy™, and VoluDerm™.
Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry.
Glenn Silver Lazar Partners Ltd. (646) 871-8495


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 



